TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19057405

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) at different frequencies (30, 35, 40, and 50 Hz), displacements (2-4 mm vs. 4-6 mm), and durations (30, 45, and 60 seconds)
Number of subjects: 20
Study: 16950221

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 14756387

Group type: EXPERIMENTAL
Intervention: Regitine 40 mg tablet formulation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vasomax 40 mg tablet formulation
Number of subjects: 36
Study: 11442181

Group type: EXPERIMENTAL
Intervention: Visual Activities Questionnaire (VAQ)
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Symptoms attributed to glaucoma
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Central and pericentral visual field measures
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Simulated binocular visual field scores
Number of subjects: 607
Study: 9776327

Group type: EXPERIMENTAL
Intervention: Antiepileptic drug treatment (AEDs)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Post-drug discontinuation assessment
Number of subjects: 102
Study: 8112232

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 3053457

Group type: COMPARATOR
Intervention: No specific infection prophylaxis in a conventional hospital room (control, 100 patients)
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Prophylactic systemic antibiotics (PSA) in a conventional hospital room (PSA group, 101 patients)
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Decontamination and isolation in a laminar air flow (LAF) room (LAF group, 65 patients)
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: PSA in an LAF room (LAF+PSA group, 76 patients)
Number of subjects: 342
Study: 31702883

Group type: EXPERIMENTAL
Intervention: Difelikefalin (0.5 μg/kg)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study: 30611123

Group type: EXPERIMENTAL
Intervention: Cancer patients undergoing coronary angiography
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Cancer patients
Number of subjects: 480

Group type: COMPARATOR
Intervention: Non-cancer patients (control)
Number of subjects: 480
Study: 27397551

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy without antifungal prophylaxis
Number of subjects: 969
Study: 25938241

Group type: EXPERIMENTAL
Intervention: Guided internet-based cognitive-behavioral therapy (iCBT) for 9 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 76
Study: 24634923

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 144
Study: 20089204

Group type: EXPERIMENTAL
Intervention: B-vitamin supplements (folate 1 mg, vitamin B12 500 microg, vitamin B6 10 mg)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study: 19127918

Group type: EXPERIMENTAL
Intervention: Warm needle moxibustion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral administration of tablet Caltrate with Vit D2
Number of subjects: 40
Study: 16859470

Group type: EXPERIMENTAL
Intervention: Intrarectal and anal EMLA cream (subgroup A)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Ultrasound gel as placebo (subgroup B)
Number of subjects: 98
Study: 14516238

Group type: EXPERIMENTAL
Intervention: Internet-driven treatment of posttraumatic stress
Number of subjects: 101

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 101
Study: 10918946

Group type: EXPERIMENTAL
Intervention: Beraprost (CAS 88475‐69‐8)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cilostazol (CAS 73963‐72‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 8865639

Group type: EXPERIMENTAL
Intervention: Frequency modulation (FM) detection with modulation rates of 2, 5, 10, and 20 Hz for carrier frequencies up to 4 kHz.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined FM and amplitude modulation (AM) detection for a 1-kHz carrier with fm = 2 Hz.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FM detection in quiet for carrier frequencies of 0.25, 1.0, and 6.0 kHz.
Number of subjects: 0
Study: 1633720

Group type: EXPERIMENTAL
Intervention: 200 mg hidrosmin, 1 capsule 3-times daily for 45 days
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo, 1 capsule 3-times daily for 45 days
Number of subjects: 57
Study: 6510452

Group type: EXPERIMENTAL
Intervention: Sustained-release isosorbide dinitrate (ISDN) 40 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31372762

Group type: EXPERIMENTAL
Intervention: Metabolomic profiling in patients with myasthenia gravis (MG)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Rheumatoid arthritis (RA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 46
Study: 28073949

Group type: EXPERIMENTAL
Intervention: Monetary incentives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct feedback (safety messaging)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monetary incentives and direct feedback combined
Number of subjects: 0
Study: 27473188

Group type: EXPERIMENTAL
Intervention: Ultra-micronized palmitoylethanolamide (um-PEA) 600 mg twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23512705

Group type: EXPERIMENTAL
Intervention: IBHB (300 mg, twice daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 23196811

Group type: EXPERIMENTAL
Intervention: Navilas laser system by experienced operator
Number of subjects: 2

Group type: COMPARATOR
Intervention: Navilas laser system by inexperienced operator
Number of subjects: 2
Study: 20637968

Group type: EXPERIMENTAL
Intervention: Crushed pellets from MS-sNT (60 mg morphine/2.4 mg naltrexone)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Naltrexone solution (2.4 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whole MS-sNT capsule (60 mg morphine/2.4 mg naltrexone)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Crushed MS-sNT
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whole MS-sNT
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Naltrexone solution
Number of subjects: 24
Study: 17252564

Group type: EXPERIMENTAL
Intervention: Chemotherapy intensification (Capizzi II)
Number of subjects: 0
Study: 16226759

Group type: EXPERIMENTAL
Intervention: 1 mg sublingual nitroglycerin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 12109416

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 90
Study: 9925046

Group type: EXPERIMENTAL
Intervention: Self-presentation condition (patients presented themselves as successful copers)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Problem disclosure condition (patients discussed problems with managing their illness)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (patients viewed a medical videotape about adjusting to dialysis)
Number of subjects: 42
Study: 7485884

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Mini-lap cholecystectomy
Number of subjects: 1078
Study: 2123603

Group type: EXPERIMENTAL
Intervention: Pericardial friction rub present
Number of subjects: 810

Group type: COMPARATOR
Intervention: No pericardial friction rub
Number of subjects: 810
Study: 7325345

Group type: EXPERIMENTAL
Intervention: Fentanyl epidurally (0.1‐0.2 mg diluted with 0.9% saline solution)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Systemic opiate therapy by intramuscular application of piritramide (Dipidolor, 15‐25 mg)
Number of subjects: 20
Study: 30628797

Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy with transference work interventions
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dynamic psychotherapy without transference work interventions
Number of subjects: 100
Study: 28218555

Group type: EXPERIMENTAL
Intervention: Millard's technique combined with McComb's technique
Number of subjects: 359

Group type: COMPARATOR
Intervention: Tennison‐Randall's technique
Number of subjects: 359

Group type: COMPARATOR
Intervention: Center's own technique with nose plugs
Number of subjects: 359
Study: 25070350

Group type: EXPERIMENTAL
Intervention: Aliskiren
Number of subjects: 126

Group type: COMPARATOR
Intervention: Losartan or Ramipril
Number of subjects: 126
Study: 23514242

Group type: EXPERIMENTAL
Intervention: Real Time Medication Monitoring system (RTMM) with tailored text-messages
Number of subjects: 220
Study: 21291439

Group type: EXPERIMENTAL
Intervention: Parents in treatment for depression
Number of subjects: 223

Group type: COMPARATOR
Intervention: Nondepressed parents (control group)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Parents' level of depression
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Parental acceptance
Number of subjects: 223
Study: 19620162

Group type: EXPERIMENTAL
Intervention: First examination with high-risk findings
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: First examination with low-risk findings
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Second examination with high-risk findings
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Second examination with no adenomas
Number of subjects: 564
Study: 16430412

Group type: EXPERIMENTAL
Intervention: Caudal ketamine (0.25 mg.kg(‐1)) plus lidocaine (2%, 2 mg.kg(‐1))
Number of subjects: 62

Group type: COMPARATOR
Intervention: Caudal ketamine (0.25 mg.kg(‐1)) plus tramadol (1 mg.kg(‐1))
Number of subjects: 62
Study: 12830445

Group type: EXPERIMENTAL
Intervention: Short daily hemodialysis (n = 11)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Long nocturnal hemodialysis (n = 12)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional thrice-weekly hemodialysis (n = 22)
Number of subjects: 45
Study: 10857518

Group type: EXPERIMENTAL
Intervention: Respiratory muscle training (three series of 15 contractions against an expiratory resistance at 60% maximum expiratory pressure [PEmax] two times a day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group performed breathing exercises to enhance maximal inspirations
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Respiratory muscle training
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Respiratory muscle weakness (part 1)
Number of subjects: 18
Study: 9337184

Group type: COMPARATOR
Intervention: Heparin (5000 U bolus followed by 1000 to 1200 U/h)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Low-dose hirulog (0.125 mg/kg bolus followed by 0.25 mg x kg(‐1) x h(‐1) for 12 hours then 0.125 mg x kg(‐1) x h(‐1))
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: High-dose hirulog (0.25 mg/kg bolus followed by 0.5 mg x kg(‐1) x h(‐1) for 12 hours then 0.25 mg x kg(‐1) x h(‐1))
Number of subjects: 412

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Low-dose hirulog
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: High-dose hirulog
Number of subjects: 412
Study: 8437833

Group type: EXPERIMENTAL
Intervention: Diode laser treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 19
Study: 3466935

Group type: EXPERIMENTAL
Intervention: Midazolam alone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diazepam alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Midazolam + Fentanyl
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diazepam + Fentanyl
Number of subjects: 24
Study: 30374692

Group type: EXPERIMENTAL
Intervention: 100 µg IV CRH
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 26296327

Group type: EXPERIMENTAL
Intervention: PVCi-CMP group (96 patients)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (72 patients)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 168
Study: 24378745

Group type: EXPERIMENTAL
Intervention: d‐amphetamine (0.3 mg/kg, p.o.)
Number of subjects: 33

Group type: COMPARATOR
Intervention: lactose placebo
Number of subjects: 33
Study: 23141813

Group type: EXPERIMENTAL
Intervention: AMG 145 70 mg every 2 weeks
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: AMG 145 105 mg every 2 weeks
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: AMG 145 140 mg every 2 weeks
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: AMG 145 280 mg every 4 weeks
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: AMG 145 350 mg every 4 weeks
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: AMG 145 420 mg every 4 weeks
Number of subjects: 631

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 631
Study: 19952829

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (4 kcal·kg(‐1)·wk(‐1)) for 6 months
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (8 kcal·kg(‐1)·wk(‐1)) for 6 months
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (12 kcal·kg(‐1)·wk(‐1)) for 6 months
Number of subjects: 464

Group type: COMPARATOR
Intervention: Nonexercise control
Number of subjects: 464
Study: 18082224

Group type: EXPERIMENTAL
Intervention: Intravesical bacillus Calmette-Guerin
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 17238812

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Travoprost 0.004%
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 73
Study: 15122555

Group type: EXPERIMENTAL
Intervention: Viewing a treatment simulation before surgery
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Patients who overestimated discomfort
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Psychologically distressed patients before surgery
Number of subjects: 184

Group type: COMPARATOR
Intervention: Standard presurgical consultation without treatment simulation
Number of subjects: 184
Study: 11476123

Group type: EXPERIMENTAL
Intervention: Olanzapine (10 mg for first two injections; 5 mg for third injection)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg for first two injections; 1 mg for third injection)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo (placebo for first two injections; olanzapine 10 mg for third injection)
Number of subjects: 201
Study: 9550531

Group type: EXPERIMENTAL
Intervention: Acute spinal cord injury
Number of subjects: 100
Study: 7840527

Group type: EXPERIMENTAL
Intervention: CAV-E (cyclophosphamide 1000 mg/m2, adriamycin 50 mg/m2, vincristine 2 mg, plus etoposide 100 mg/m2)
Number of subjects: 75

Group type: COMPARATOR
Intervention: CAV-T (teniposide 60 mg/m2 on days 2, 3, 4)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: alpha-interferon (3 x 10(6) I.U., i.m. daily x 9 months)
Number of subjects: 75

Group type: COMPARATOR
Intervention: no treatment
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: CAV-E and CAV-T
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: CAV-E
Number of subjects: 75

Group type: COMPARATOR
Intervention: CAV-T
Number of subjects: 75
Study: 3295323

Group type: EXPERIMENTAL
Intervention: Cefixime (CFIX) 100 mg b.i.d.
Number of subjects: 252

Group type: COMPARATOR
Intervention: Cefroxadine (CXD) 250 mg t.i.d.
Number of subjects: 252
Study: 28741624

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive (30 μg ethinyl estradiol/0.15 mg levonorgestrel)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 27565187

Group type: EXPERIMENTAL
Intervention: Noncompetitive exergames with extrinsically framed health messages
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Competitive exergames with intrinsically framed health messages
Number of subjects: 595

Group type: COMPARATOR
Intervention: Adolescents
Number of subjects: 595
Study: 26341047

Group type: EXPERIMENTAL
Intervention: Proficiency-Based Progression (PBP) training plus simulator (group C)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Simulator training (group B)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Traditional training (group A) (control)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Comparison of groups for achieving proficiency benchmark
Number of subjects: 44
Study: 25947930

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg sublingual melatonin
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg sublingual melatonin
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg sublingual melatonin
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 21038019

Group type: EXPERIMENTAL
Intervention: Opt‐FP 400 µg
Number of subjects: 20
Study: 18478468

Group type: EXPERIMENTAL
Intervention: Lymphadenectomy adjacent to inferior mesenteric artery root (Group D(3))
Number of subjects: 260

Group type: COMPARATOR
Intervention: No lymphadenectomy adjacent to inferior mesenteric artery root (Group D(2))
Number of subjects: 260
Study: 16575041

Group type: EXPERIMENTAL
Intervention: Suction catheter (SC) guided technique
Number of subjects: 243

Group type: COMPARATOR
Intervention: Digital technique
Number of subjects: 243
Study: 12883897

Group type: EXPERIMENTAL
Intervention: Voluntary exercise (alternate flexion-extensions of both lower legs with a weight of about 2.5% of body mass) for 20 seconds (brief voluntary exercise)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Passive movement (without weights, performed by experimenters pulling ropes attached to the subjects' ankles) for 20 seconds (brief passive movement)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Voluntary exercise for 3 minutes (long voluntary exercise)
Number of subjects: 14
Study: 10714758

Group type: EXPERIMENTAL
Intervention: Premixed insulin therapy via pen-injector (Novopen II)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Patient-mixed insulin therapy via conventional syringe
Number of subjects: 20
Study: 8957600

Group type: EXPERIMENTAL
Intervention: Patients with hypertensive heart disease
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 15
Study: 8234642

Group type: EXPERIMENTAL
Intervention: Nightguard vital bleaching (overnight insertion of mouthguard at bedtime)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nightguard vital bleaching (3-hour exposure with replenishment of test solution hourly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control solution (glycerin)
Number of subjects: 0
Study: 3513425

Group type: EXPERIMENTAL
Intervention: Intravesical 0.5% aminocaproic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% sodium chloride irrigation
Number of subjects: 0
Study: 29641362

Group type: EXPERIMENTAL
Intervention: Lidocaine patch (175 mg) applied to umbilical trocar site
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no lidocaine patch)
Number of subjects: 40
Study: 27095126

Group type: EXPERIMENTAL
Intervention: Video laryngoscopy (VL)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL)
Number of subjects: 140
Study: 24261547

Group type: EXPERIMENTAL
Intervention: Family-centred music therapy (FCMT) for 16 weeks in addition to early intervention programmes
Number of subjects: 23

Group type: COMPARATOR
Intervention: Early intervention programme only
Number of subjects: 23
Study: 22373758

Group type: EXPERIMENTAL
Intervention: Steady competitive work
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Steady noncompetitive work
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Working clients (steady competitive and noncompetitive)
Number of subjects: 187

Group type: COMPARATOR
Intervention: No work
Number of subjects: 187
Study: 20487009

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Tokuyama Bond Force
Number of subjects: 22
Study: 18721703

Group type: EXPERIMENTAL
Intervention: Intracameral moxifloxacin 0.5% (250 mug/0.050 mL)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Balanced salt solution (control)
Number of subjects: 47
Study: 16002918

Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF‐DPI) 400 microg qd
Number of subjects: 53

Group type: COMPARATOR
Intervention: HFA‐BDP 200 microg two puffs MDI bid
Number of subjects: 53

Group type: COMPARATOR
Intervention: CFC‐BDP 400 microg two puffs MDI bid
Number of subjects: 53
Study: 12855265

Group type: EXPERIMENTAL
Intervention: Bio-chemotherapy (bio-CT)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Chemotherapy (CT)
Number of subjects: 178
Study: 10568212

Group type: EXPERIMENTAL
Intervention: DHEP lecithin gel (1.3% DHEP and 2.4% lecithin)
Number of subjects: 100

Group type: COMPARATOR
Intervention: DHEP gel (without lecithin)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: DHEP lecithin gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: DHEP gel
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 100
Study: 8839597

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Failure to maintain gut function by way of early enteral nutrition
Number of subjects: 0
Study: 1826871

Group type: EXPERIMENTAL
Intervention: lovastatin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: gemfibrozil
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 7144695

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, vincristine, plus prednisone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cyclophosphamide, doxorubicin, vincristine, plus prednisone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Exploratory laparotomy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Repeat lymphangiograms
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Gallium scans
Number of subjects: 100
Study: 31335764

Group type: EXPERIMENTAL
Intervention: Ileostomy formation
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Ileostomy takedown
Number of subjects: 135
Study: 31023403

Group type: EXPERIMENTAL
Intervention: Blood Flow Restricted (BFR) rowing exercise
Number of subjects: 20
Study: 28146015

Group type: EXPERIMENTAL
Intervention: Revision surgery for reherniation
Number of subjects: 810

Group type: COMPARATOR
Intervention: Primary discectomy
Number of subjects: 810